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LETTER-TO-THE-EDITOR
Hypomagnesaemia As a Mortality Risk Factor in 
Protein-energy Malnutrition
Sir,
Protein-energy malnutrition (PEM) is one of the 
leading causes of childhood morbidity and mortali- 
ty in developing countries. The case-fatality rate for 
PEM was 28.4% despite hospitalization (1).
Magnesium (Mg) modulates vasomotor tone, blood 
pressure, and peripheral blood flow. Mg deficiency 
was shown to trigger vasoconstriction and enhance 
vascular endothelial injury (2). On the other hand, 
endothelin-1 (ET-1) is a potent vasoconstrictor pep-
tide, produced by vascular endothelial cells (3). We 
investigated the effects of hypomagnesaemia 
on mortality and other mortality risk factors in pa-
tients with PEM. 
The study included 25 children with PEM. Their 
mean age was 4.7+2.9 months. In the study groups, 
malnutrition was not related to malabsorption. 
Malnutrition was diagnosed using the Wellcome 
classification. All children had severe malnutri-
tion without malabsorption (mean weight-for-
height z-score was -3.1). Weights were measured 
using the same equipment by the same observer. 
Weights were measured to the nearest 10 g using a 
digital electronic instrument (Seca 727 Digital Baby 
Scale, serial interface RS 232, Seca Corporation, 
Vogel&Holke, Germany). Venous blood samples 
of the children were collected from the antecubital 
vein for serum Mg, and ET-1 measurements were 
obtained at admission. Blood samples were imme-
diately centrifuged, separated, and stored at -80 °C 
before analysis. Serum magnesium levels of the 25 
surviving and deceased patients were studied by 
spectrophotometrical xylidyl blue method (Olym-
pus AU2700 autoanalyzer, commercially-available 
Boehringer Mannheim System kit). Reference range 
was accepted as 1.71-2.5 mg/dL. ET-1 levels were 
studied with ELISA method (BioTEK Power-WXS, 
commercially-available kit; Catalog No. 900-022). 
Mann-Whitney U tests and odds ratio were used 
for the comparison of means of each group and for 
ratios of each group respectively. 
Informed consent was obtained from parents. The 
Ethics Committee of the Faculty approved the 
study.
Serum Mg and ET-1 levels of the patients with PEM 
were prospectively evaluated. During the follow-up 
period, four (16%) patients died within four days 
after admission. Although serum Mg levels were 
significantly lower in the patients who died, se-
rum ET-1 levels were slightly higher at admission 
(Table). Serum Mg levels were lower than normal 
value in three (75.0%) of the four deceased and in 
six (28.6%) of the 21 surviving patients with PEM. 
The odds ratio (odds ratio=(3/1)/(6/15)=7.5) for 
mortality was 7.5 times higher in the malnour-
ished children with hypomagnesaemia (n=9) than 
in the malnourished children without hypomagne-
saemia (n=16). When the mean weight-for-height 
measurements of the deceased and the surviving 
patients were evaluated, no significant difference 
(p>0.05) was observed between them.  
We found significant differences in serum Mg levels 
but not in serum ET-1 levels between the surviving 
and the deceased groups of patients with PEM. Se-
rum Mg levels were significantly lower in the pae-
diatric patients (68.8%) in the intensive care unit 
compared to the control group (12.0%) (p<0.001) 
(4). Furthermore, Mg intake from drinking-water 
was suggested to exert a significant protective ef-
fect on the risk of cerebrovascular disease and death 
from stroke (5). Mg is one of the most abundant 
ions in human cells, and its serum concentration is 
remarkably constant in healthy subjects. Although 
the measurement of serum Mg does not always 
reflect the overall status of Mg metabolism, serum 
Mg correlates well with intracellular-free Mg, the 
physiological active form of the elements (6). How-
ever, even small alteration in the extracellular Mg 
concentration can influence human organism and 
metabolism. 
When ET-1 levels were investigated as a mortality 
risk factor, Kunz et al. reported that plasma ET-1 
levels were slightly higher but not significant in 
haemodialyzed patients with cardiovascular his-
tory compared to haemodialyzed patients without 
cardiovascular history (7). Adversly, plasma  ET-1 
concentrations are strongly related to outcome af-Karakelleoglu C et al. Hypomagnesaemia as a mortality risk factor
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ter acute myocardial infarction (p<0.0001) and pro-
vide prognostic information independent of clini-
cal and biochemical variables. On the other hand, 
an experimental study showed that magnesium 
deficiency was associated with increased ET-1 levels 
and with significant proaggregatory and coagula-
tion alterations (8). When Serebruany et al. inves-
tigated alterations in various haemostatic factors 
as risk factors for survival after acute myocardial 
infarction (9), no significant differences was found 
in the ET-1 plasma concentrations during occlu-
sion between the surviving and the non-surviving 
groups in this study, although plasma baseline ET-1 
levels was slightly higher but not significant in the 
deceased swine (9). This result was similar to ours. 
However, results of a previous study showed that 
the mean serum ET-1 levels in the group with low 
magnesium levels were significantly higher than 
that of the group with normal magnesium levels 
(p<0.05) in malnourished children (10). This dis-
crepancy in our results may be related to the low 
number of the deceased patients with PEM. On the 
other hand, it has been shown a release of TNFα 
and IL-1 at approximately one week after the ad-
ministration of a low Mg diet in mice (11). Results 
of another study showed that hypomagnesaemia 
could stimulate endothelial cells to produce and re-
lease ET-1 (12). So, the sampling time may be also 
important. 
Since the number of cases chosen was small in our 
study, additional studies on pathophysiology and 
clinical importance of hypomagnesaemia are need-
ed. The findings of the present study calls for giving 
attention to hypomagnesaemia as a mortality risk 
factor in PEM. 
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Table. Mean+SD and significance values for serum Mg and ET-1 levels in the surviving and 








Mg (mg/dL) 2,06+0,33 1,55+0,43 <0.05
ET-1 (pg/mL) 42,23+14,81 45,17+13,95 >0.05
ET=Endothelin; Mg=Magnesium; PEM=Protein-energy malnutrition; SD=Standard deviation 